RADX · Radiopharm Theranostics Ltd
Market Cap
$34.84M
Shares
14.46M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$3.63M
+1114.3%
FY2025
Net Income
-$38.34M
+20%
FY2025
Gross Margin
1.08%
-98.9pp
FY2025
Operating Margin
-1050.63%
+14726.6pp
FY2025
Diluted EPS
-$1.76
+85.8%
FY2025
Operating Cash Flow
-$36.65M
-59.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| $3.63M | $299.23K | $292.36K | |
| $3.59M | — | — | |
| $39.28K | $299.23K | $292.36K | |
| 1.08% | 100% | 100% | |
| $27.52M | $23.09M | $22.63M | |
| $14.64M | $13.04M | $12.23M | |
| -$38.17M | -$47.21M | -$34.49M | |
| -1050.63% | -15777.22% | -11796.15% | |
| $65.3K | $642.89K | $86.09K | |
| -$38.24M | -$47.85M | -$34.57M | |
| $103.29K | $96.36K | $38.01K | |
| -$38.34M | -$47.95M | -$34.61M | |
| -1055.27% | -16024.28% | -11838.59% | |
| USD/shares | -$1.76 | -$12.41 | -$11.32 |
| USD/shares | -$1.76 | -$12.41 | -$11.32 |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.